ICVX priced its registered public offering of 8.4 million shares at $8.10 per share for gross proceeds of $67.8 million. 临床一期RSV候选疫苗（二价）$Icosavax(ICVX)$
| 发布于: 修改于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
ICVX priced its registered public offering of 8.4 million shares at $8.10 per share for gross proceeds of $67.8 million. 临床一期RSV候选疫苗（二价）$Icosavax(ICVX)$